Optimizing Care for Hereditary Angioedema: Strategies for Personalizing Treatment Selection and Effective Patient Communication
- CME / AMA PRA Category 1 Credit™
- MOC / ABAI MOC Points
- MIPS Improvement Activity Under MACRA
Hereditary angioedema (HAE) is a rare genetic disease which causes sporadic swelling in the face, neck, limbs, and abdomen. The frequency, severity, and character of attacks can vary widely, and patients with HAE frequently have delayed diagnoses or are misdiagnosed. Effective targeted agents and current evidence-based recommendations on their use are often not considered. Regular monitoring of attacks is necessary to ensure proper care, but is often omitted.
This activity will improve the management of patients with HAE by reviewing current guidelines for the diagnosis of HAE, informing clinicians about the safety and efficacy of approved HAE therapies and recommendations for their use, and outlining the importance of using patient-reporting instruments in monitoring the frequency and severity of HAE episodes and patient quality of life.
Welcome and Introductions
Delays in Referrals of Suspected HAE Cases
Guideline-based Treatment of HAE
Improving Disease Monitoring and Communication Between Physicians and Patients
Q&A Session and Concluding Remarks
This activity is intended for allergists, immunologists, and primary care providers who are involved in the diagnosis and treatment of patients with hereditary angioedema.
At the conclusion of this activity, participants should be able to:
- Integrate current guidelines for diagnoses of patients with HAE into routine practice
- Assess current safety and efficacy data of approved therapies for HAE
- Evaluate the use of patient-reporting instruments (HAE-AS and HAE-QoL) in monitoring treatment response and quality of life
The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: firstname.lastname@example.org.
MIPS CREDIT DESIGNATION
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
Professor of Medicine
Clinical Director, US HAEA Angioedema Center
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA
Dr. Riedl received a Master of Science degree in clinical research from UCLA and holds board certifications in allergy-immunology and clinical pharmacology. He serves on numerous editorial boards and scientific committees, as well as appointed expert panels for the Food and Drug Administration (FDA) and the National Institutes of Health (NlH). He directs an active clinical research program at UCSD focused on angioedema and immunodeficiency conditions.
Associate Clinical Professor
University of Colorado Health Sciences Center
Physician/Owner, Asthma and Allergy Associates, PC
Dr. Soteres received his medical degree in 1998 from Tulane University School of Medicine in New Orleans, while simultaneously earning a Master's in Public Health. He completed a four-year combined residency in internal medicine and pediatrics and was a Chief Resident in internal medicine. He completed his allergy and immunology fellowship at Tulane and is board-certified in allergy and immunology.
In the clinic, he diagnoses and treats asthma, exercise-induced asthma, other respiratory problems, environmental and food allergies, skin disorders, and immunologic diseases. He enjoys helping people with ordinary and rare and complicated diseases. Dr. Sorteres has been a primary investigator for studies of asthma, allergy, and hereditary angioedema. He has also studied treatments for COPD and migraine and participates on many national advisory boards.
Volunteer accomplishments include founding a support group for families of kids with severe food allergy called MOSAIC (Mothers of Severely Allergic Infants and Children), organizing a local journal club for allergy doctors in the region, mentoring medical and physician assistant students, and participating in the D20 physician advisory board.
AMERICAN BOARD OF ALLERGY AND IMMUNOLOGY (ABAI) MOC POINTS
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Steering Committee Disclosures
Marc Riedl, MD, MS: Consultant/Independent Contractor: Adverum, BioCryst, CSL Behring, Ionis, KalVista, Pharming, Shire; Grant/Research Support: BioCryst, CSL Behring, Pharming, Shire; Speaker's Bureau: CSL Behring, Pharming, Shire
Daniel F. Soteres, MD, MPH: Consultant/Independent Contractor: Ruconest, Shire; Grant/Research Support: BioCryst, CSL Behring, Shire; Speaker's Bureau: CSL Behring, Ruconest, Shire
Non-faculty Content Contributors Disclosures
Terry Ann Glauser, MD, MPH; Blair St. Amand; Ashley Marostica, MSN, RN, CCM; Lindsey Scott, PT, DPT, ATC: Nothing to disclose
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT
Provided by the Potomac Center for Medical Education
This activity is supported by educational grants from CSL Behring and Pharming Healthcare, Inc.
FIGHTING THE UPHILL BATTLE: Current Evidence in Obesity Management
Credits 1.00 (60 min)
Improving Outcomes for Patients with Severe Hypercholesterolemia
Credits 1.00 (60 min)